HHC
NVO

Hutchin Hill Capital’s Novo Nordisk NVO Stock Holding History

Hutchin Hill Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-200,000
Closed -$4.57M – 700
2014
Q1 		$4.57M Buy
+200,000
New +$4.26M 0.24% 72

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Hutchin Hill Capital's NVO Position: Q2 2014 in Review

Hutchin Hill Capital sold out of Novo Nordisk (NVO) in Q2 2014, closing a stake of 200,000 shares — an estimated $4.57M sold.

Hutchin Hill Capital first reported a position in NVO in Q1 2014 and held it in 1 quarter. The position peaked at $4.57M in Q1 2014. 473 funds tracked by Wall St. Rank hold NVO as of Q2 2014.

  • Hutchin Hill Capital reported no remaining Novo Nordisk position as of Q2 2014 after selling out during the quarter.
  • Hutchin Hill Capital sold 200,000 Novo Nordisk shares in Q2 2014, an estimated $4.57M.
  • Hutchin Hill Capital first reported a position in Novo Nordisk in Q1 2014 and held it in 1 quarter.
  • Hutchin Hill Capital's Novo Nordisk position peaked at $4.57M in Q1 2014.
  • 473 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2014.

Based on Hutchin Hill Capital's 13F filing for Q2 2014, filed 14 Aug 2014.